At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Standard treatment only +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Bioskin Ten-7 vs. Standard Treatment on Patient Reported Outcomes and Cytokine.
In Brief
A clinical study evaluating Standard treatment only and Standard treatment plus Bioskin Ten-7 knee brace for Osteoarthritis of the Knee. Completed, enrolled 40 participants.
Detailed Summary
The objectives of the study are 1.) to evaluate pain relief following the application of the Bioskin Ten-7 knee brace and 2.) to determine if use of the Bioskin Ten-7 knee brace is more effective at reducing inflammation than standard of care alone using synovial fluid cytokine analysis and validated outcome measures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedNov 2014
Primary CompletionApr 2016
TodayJul 2026
First PostedNov 19, 2014
Enrollment StartMay 1, 2013
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 11.6 years ago
Interventions
Standard treatment onlydrug
Standard treatment such as NSAIDs and injections
Standard treatment plus Bioskin Ten-7 knee bracedevice
Standard treatment such as NSAIDs and injections plus Bioskin Ten-7 knee brace.